Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe by Brennan, P et al.
Short Communication
Tobacco smoking, body mass index, hypertension, and kidney
cancer risk in central and eastern Europe
P Brennan*,1, O van der Hel
1, LE Moore
2, D Zaridze
3, V Matveev
4, I Holcatova
5, V Janout
6, H Kollarova
6,
L Foretova
7, N Szeszenia-Dabrowska
8, D Mates
9, N Rothman
2, P Boffetta
1 and W-H Chow
2
1International Agency for Research on Cancer (IARC), Lyon, France;
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH,
DHHS, MD, USA;
3Institute of Carcinogenesis, Cancer Research Center, Moscow, Russia;
4Department of Urology, NN Blokhin Cancer Research Centre,
Moscow, Russia;
5Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic;
6Department of Preventive Medicine, Faculty of
Medicine, Palacky University, Olomouc, Czech Republic;
7Department of Cancer Epidemiology & Genetics, Masaryk Memorial Cancer Institute, Brno,
Czech Republic;
8Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland;
9Institute of Public Health, Bucharest, Romania
In a case–control study of kidney cancer in four central European countries, with 1097 incident cases and 1476 controls, we found an
increased risk for self-reported hypertension and for obesity. Additional unknown risk factors are likely to be responsible for the high
rates of kidney cancer in this region.
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Kidney cancer accounts for 1.9% of all malignancies, with
approximately 189000 new cases diagnosed globally each year
and the incidence varying more than 10-fold around the world,
with the highest rates generally observed in central European
countries and among blacks in the United States (Murai and Oya,
2004). Smoking is an established risk factor, although the increase
in risk is moderate (IARC, 2004). Other possible risk factors are
hypertension and obesity, with potentially differing risks for men
and women (Shapiro et al, 1999; Bergstrom et al, 2001). To
examine the risk factors for kidney cancer in central Europe, we
conducted a large multicenter case–control study in Czech
Republic, Poland, Russia, and Romania. We present here data on
the role of smoking, hypertension, and body mass index (BMI) in
this high-risk population.
MATERIALS AND METHODS
This hospital-based case–control study was conducted in seven
centres (Moscow (Russia), Bucharest (Romania), Lodz (Poland),
and Prague, Olomouc, Ceske Budejovice, and Brno (Czech
Republic)). A total of 1097 newly diagnosed, histologically
confirmed, renal parenchymal cancers (ICD-O-2 code C64)
between 20 and 79 years of age were recruited during August
1999 and January 2003. Trained medical staff reviewed medical
records to extract relevant diagnostic information, including date
and method of diagnosis, histologic type, tumour location, stage,
and grade. Eligible controls (n¼1476) were admitted to the same
hospitals as the cases for conditions unrelated to smoking or
genitourinary disorders (except for benign prostatic hyperplasia)
between August 1998 and March 2003. No single disease made up
more than 20% of the control group. Both cases and controls had to
be residents of the study areas for at least 1 year. The response rate
for cases ranged from 90 to 98.6% and for the controls, 90.3–96.1%.
Trained interviewers used standardised questionnaires at all
centres to elicit information on demographic background, smok-
ing, alcohol drinking, dietary practices, height, weight, medical
history, family history of cancer, residential history, and occupa-
tional history.
Smoking status (never smoker, former smoker, current smoker)
was defined as status 2 years before interview. Packyears were used
as a measure of cumulative tobacco smoking and were calculated
by the number of cigarettes smoked per day multiplied by years of
smoking and divided by 20. History of hypertension was self-
reported and a positive history was restricted to patients who
reported being treated for hypertension. The weight in kilograms
was ascertained for 2 years before the interview. Body mass index
was calculated by dividing the weight by the square of the height in
metres.
Kidney cancer risks were estimated by odds ratios (ORs) and
95% confidence intervals (CIs) using logistic regression analysis,
with adjustment for age (5-years interval), smoking (current,
former, and never smokers), BMI in five categories (o25, 25–27.4,
27.5–29.9, 30–34.9, X35), history of hypertension treatment (no
vs yes), and country, where appropriate. Heterogeneity tests were
used to evaluate differences among countries by including
country–exposure interaction terms in the logistic models, and
likelihood ratio tests to evaluate the statistical significance of the
interaction terms.
RESULTS
The study population consisted of 1097 kidney cancer cases (648
men and 449 women) and 1476 controls (952 men and 524 women)
(Tables 1 and 2). Among cases, tumour stage at diagnosis was
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ysimilar for both sexes, with 9.2% of men and 6.9% of women
having M1 stage and 10.3% of men and 8.8% of women having
XN1 stage, 83% of cases were clear cell carcinoma and 6%
papillary carcinoma.
Smoking was not associated with an increased risk of kidney
cancer, and no dose–response was seen with increasing levels of
cigarette consumption. The findings were similar for all patients
combined or in men and women separately. In addition, no
significant heterogeneity between the four countries was observed.
Increasing BMI was positively associated with kidney cancer
overall (test for linear trend, P¼0.011; Table 3). Compared to
those with BMI o25, the OR among those with BMI 30–35 was
1.38 (95% CIs: 1.09, 1.75), and among those with BMI X35 was
1.29 (95% CIs: 0.88, 1.89). The excess risks, however, were
restricted to men, risk nearly doubling among those in the highest
category of BMI (OR¼1.72; (95% CIs: 1.01, 2.94)). For women, no
increase in risk was observed either overall or in any of the four
countries separately. Approximately 14% of cases were estimated
to be attributable to a BMI of greater than 25 (95% CI 3–23%).
An increased risk was observed for patients who reported
having been treated for hypertension more than 2 years before
interview compared to those who did not (OR¼1.25 (95% CIs:
1.06, 1.49)) (Table 4). The effect was more prominent among
women (OR¼1.47 (95% CIs: 1.11, 1.95)) than men. The results
were largely unaltered when hypertension was defined as ever
having been diagnosed with hypertension regardless of treatment
status. Approximately 9% of cases were estimated to be
attributable to hypertension (95% CIs 2–16%).
Our analysis included all histological types of carcinoma of the
renal parenchyma, including 17% of cases who had an histology
other than clear cell type, excluding these cases had little influence
on the results.
DISCUSSION
This study provides evidence that increased BMI and a history of
hypertension are risk factors for kidney cancer in high-risk areas
of central and eastern Europe, countries in which data on kidney
cancer have been limited. The increased risk associated with BMI
was more pronounced among men, while the increased risk for
history of hypertension was more pronounced among women.
Our findings of increasing risks for kidney cancer with
increasing BMI agree with most other studies. A recent evaluation
by an IARC working group on the effects of body weight and
adiposity showed that all but one of the 19 reviewed studies found
a more than two-fold increase in kidney cancer risk among obese
men and women compared with those of normal weight (IARC,
2002). In addition, two recent cohort studies confirmed a role for
BMI (Bjorge et al, 2004; van Dijk et al, 2004). A potential
mechanism by which obesity may increase kidney cancer risk
involves increased levels of insulin-like growth factor (IGF) or lipid
peroxidation. Increasing BMI is associated with elevated levels of
fasting serum and free IGF-I among both men and women (Frystyk
et al, 1995). Insulin-like growth factor-I stimulates cell proliferation
Table 2 Odds ratio of kidney cancer for tobacco smoking
Men Women Total
Cases Controls OR
a 95% CI Cases Controls OR
a 95% CI Cases Controls OR
a 95% CI
Smoking NN NN NN
Never smokers 170 232 1.00 Ref
b 340 368 1.00 Ref 510 600 1.00 Ref
Former smokers 204 302 0.89 0.68, 1.17 47 51 1.07 0.69, 1.67 251 353 0.88 0.71, 1.11
Current smokers 273 416 0.99 0.76, 1.29 60 105 0.70 0.48, 1.02 333 521 0.87 0.71, 1.07
Never smokers 170 232 1.00 Ref 340 368 1.00 Ref 510 600 1.00 Ref
o17 packyears 150 221 0.94 0.70, 1.26 62 97 0.76 0.52, 1.11 212 318 0.85 0.67, 1.06
17–31 packyears 161 234 1.00 0.75, 1.34 32 39 0.99 0.59, 1.65 193 273 0.95 0.74, 1.21
431 packyears 165 261 0.89 0.67, 1.19 13 19 0.85 0.40, 1.78 178 280 0.85 0.66, 1.09
P-value for trend 0.49 P-value for trend 0.34 P-value for trend 0.19
aAdjusted for age, body mass index, history of hypertension and country.
bRef¼reference category.
Table 1 Descriptive characteristics of cases and controls
Men Women
Cases Controls Cases Controls
Variables N % N % N % N %
Country
Romania 63 9.7 109 11.4 32 7.1 51 9.7
Poland 56 8.6 112 11.8 43 6.6 86 16.4
Russia 163 25.4 305 32.0 154 34.3 158 30.2
Czech Republic 366 56.4 426 44.8 220 49.0 229 43.7
Total 648 100 952 100 449 100 524 100
Age (years)
o40 25 4.1 25 2.6 14 3.1 18 3.4
40–49 91 14.0 152 16.0 53 11.8 60 11.5
50–59 227 35.0 320 33.6 122 27.2 153 29.2
60–69 187 28.9 289 30.4 150 33.5 170 32.4
470 118 18.0 166 17.4 110 24.4 123 23.5
Tumour stage
T-stage
T1 117 18.8 90 20.5
T2 275 44.1 209 47.5
T3 210 33.6 126 28.6
T4 22 3.5 15 3.4
M-stage
M0 486 90.8 363 93.1
M1 49 9.2 27 6.9
N-stage
N0 505 89.7 371 91.2
N1 31 5.5 24 5.9
N2 24 4.3 10 2.4
N3 3 0.5 2 0.5
Histology
(Clear cell) Renal cell
carcinoma
538 83.0 370 82.4
Papillary renal cell
carcinoma
51 7.9 20 4.5
Other 59 9.1 59 13.1
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yand inhibits apoptosis, which could have a profound impact on
tumour growth (Yu and Rohan, 2000).
An association between hypertension and kidney cancer has also
been previously reported (McLaughlin et al, 2006). Hypertension is
hypothesised to cause renal damage directly or cause metabolic or
functional changes within the renal tubules, thus increasing the
kidney’s susceptibility to carcinogens or promoting agents (Cowley
and Roman, 1996). The relationship between kidney cancer and
hypertension is complex. McCredie and Stewart (1992) showed
that kidney cancer in hypertensive patients was related to the
duration of hypertension, suggesting that hypertension contributes
is aetiologically relevant rather than being a consequence of the
tumour (McCredie and Stewart, 1992). Also, in this connection,
cohort studies may stratify by follow-up time, several finding that
have found that the effect of hypertension is the same in the first
years of follow-up as later (Fraser et al, 1990; Coughlin et al, 1997;
Chow et al, 2000). These findings support the hypothesis that
hypertension is a risk factor for kidney cancer. Further, an
increased risk has been reported with mild hypertension that
would usually go untreated, and a decreasing risk of among those
who have experienced lowered blood pressure levels over time
(Chow et al, 2000).
Smoking is an established risk factor for kidney cancer,
although the increase in risk is weak (IARC, 2004). In a
comprehensive meta-analysis, we have recently estimated that
the increased risk for ever smokers compared to never smokers
was 38% (RR¼1.38 (95% CI: 1.28, 1.49) (Hunt et al, 2005)). There
was also a strong dose-dependent increase with increasing tobacco
consumption. However, the OR for smoking obtained from the
meta-analysis in hospital-based studies was 1.17 (95% CIs: 1.03,
1.34), whereas in population-based studies, it was 1.49 (95% CIs:
1.34, 1.66). Our current study had a 97% power of detecting an
increased risk of 40% associated with smoking, although only
about a 50% power of detecting a 20% increase in risk. One
possible conclusion is that smokers were over-represented in
hospital controls resulting in a reduced power to detect a real effect
of smoking on kidney cancer. We did compare the smoking
prevalence between the major control groups and did not detect
any heterogeneity, although a small amount of bias could not be
excluded.
Our study confirms that BMI and a history of hypertension are
risk factors for kidney cancer in central Europe, a region with the
highest incidence currently reported, but these are unlikely to
explain fully the high incidence, indicating that important causes
remain to be discovered.
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